₹923.0
-0.72% today
· 30d +7.45%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for AARTIPHARM. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-09-30
REVENUE
₹610 Cr
+45.92% YoY
NET PROFIT
₹71 Cr
+155.96% YoY
OPM
22.2%
+4.33pp YoY
EPS
₹7.88
PE 32.64
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-1.8% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
ML Forward Growth Predictions 🔒
57
SCORE / 100
Overall
6-axis composite of the sections below.
Performance
STRONG
75
Valuation
FAIR
40
Growth
DECLINING
26
Profitability
HIGH
78
Technicals
STRONG
72
Risk
MODERATE
50
Key Stats
TTM PE
32.64
P/B
3.94
52W HIGH
₹1002.4
OFF HIGH
-7.92%
DIV YIELD
0.43%
MKT CAP
₹8367 Cr
◉ Active Signals
MACDBullish5.4437
RSI(14)Neutral55.58
Street Consensus
1 analyst₹740.0
mean target
Low ₹740.0Now ₹923.0High ₹740.0
⧉ Strategy Fit 🔒